JPRN-UMIN000004787已完成2 期
Phase II study for evaluation of volume reduction surgery for Stage IV advanced gastric cancer effectively treated with S-1 based combination chemotherapy - PerSeUS-GC01
PerSeUS-GC0 个研究点目标入组 40 人开始时间: 2010年12月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of severe hypersensitivity (allergy) to any medicines 2)Administration contraindication of S-1 and combination agent 3)Continuous use of flucytosine, phenytoin or warfarin potassium 4)Active infection 5)Severe complications, such as intestinal paralysis, ileus, interstitial pneumonitis or pulmonary fibrosis, uncontrolled diabetes mellitus, heart failure, renal failure and hepatic failure 6)Watery stools or diarrhea 7)Massive pleural or abdominal effusion 8)Active double cancer 9)Pregnant or nursing females. 10)Males who are planning partners' pregnancy. 11)Not suitable for participation with any other reasons
研究者
相似试验
进行中（未招募）
1 期
Phase II-Studie zur Effizienz der vorzeitigen Reduktion von CSA/MMF bei fallendem linienspezifischen Chimärismus nach allogener Stammzelltransplantation nach Konditionierung mit low-dose TBI/Fludarabin bei älteren Patienten mit hämatologischen Erkrankungen - RIC 2006EUCTR2007-002420-15-DEniversität Leipzig200
招募中
不适用
A phase II study of the dose reduction and shortening of duration of immunosuppressant after HLA-haploidentical transplantation with post-transplantation cyclophosphamide following reduced-intensity conditioninghematologic malignanciesJPRN-UMIN000026002JSCT55
招募中
不适用
A phase II study of the dose reduction and shortening of duration of immunosuppressant after HLA-haploloidentical transplantation with post-transplantation cyclophosphamide following myeloablative conditioninghematologic malignanciesJPRN-UMIN000026001JSCT42
招募中
不适用
Phase II study exploring reduction method of Lenvatinib for the patients with advanced hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000032400Kanazawa University27
已完成
2 期
The phase II study for evaluating the effectiveness and safety of allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia with FLT3/ITD mutation. -JALSG AML209-FLT3-SCT Study (AML209-FLT3-SCT)Acute myeloid leukemiaJPRN-UMIN000003433Japan adult leukemia study group60